Replies to post #496182 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

From the AD/PD 2025 presentation we see that 313 patients completed the main trial, eligible to enroll in the OLE.

Around 18% of the 462 patients that started the main trial completed the OLE, or about 26% of the 313 patients that completed the main trail with the relevant data available. You can see that here: